Activation of JAK2/STAT3 signaling in pancreatic cancer can lead to tumorigenesis, progression, cancer stem cell maintenance, and treatment resistance (Tyagi et al. 2016). The gene discussed is STAT3; the disease is familial pancreatic carcinoma.